IBU tablet USA - engelsk - NLM (National Library of Medicine)

ibu tablet

direct _rx - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - carefully consider the potential benefits and risks of ibuprofentablets and other treatment options before deciding to use ibuprofen.use the lowest effective dose for the shortest duration consistent withindividual patient treatment goals (see warnings). ibu tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibu tablets are indicated for relief of mild to moderate pain. ibu tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibu tablets in children have not been conducted. ibu tablets are contraindicated in patients with known hypersensitivityto ibuprofen. ibu tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin orother nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions, and precautions, preexisting asthma

Acneplus 20 mg/g - 50 mg/g cream Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

acneplus 20 mg/g - 50 mg/g cream

louis widmer sa-nv - miconazole nitrate 20 mg/g; benzoyl peroxide 50 mg/g - cream - 20 mg/g - 50 mg/g - miconazole nitrate 20 mg/g; benzoyl peroxide 50 mg/g - other anti-acne preparations for topical use

Lipactin Gel 17 500 IU - 0.5 g gel Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

lipactin gel 17 500 iu - 0.5 g gel

louis widmer sa-nv - heparin sodium 17500 iu; zinc sulfate 0,5 g - gel - 17500 iu - 0,50 g - heparin sodium 175 iu/g; zinc sulfate 5 mg/g - antivirals

IBU- ibuprofen tablet USA - engelsk - NLM (National Library of Medicine)

ibu- ibuprofen tablet

remedyrepack inc. - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - carefully consider the potential benefits and risks of ibuprofentablets and other treatment options before deciding to use ibuprofen.use the lowest effective dose for the shortest duration consistent withindividual patient treatment goals (see warnings ). ibu tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibu tablets are indicated for relief of mild to moderate pain. ibu tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibu tablets in children have not been conducted. ibu tablets are contraindicated in patients with known hypersensitivityto ibuprofen. ibu tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin orother nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions, and pr

Cyanokit Den Europæiske Union - engelsk - EMA (European Medicines Agency)

cyanokit

serb sa - hydroxocobalamin - poisoning - all other therapeutic products - treatment of known or suspected cyanide poisoning.cyanokit is to be administered together with appropriate decontamination and supportive measures.

ZOLPIMIST- zolpidem tartrate spray, metered USA - engelsk - NLM (National Library of Medicine)

zolpimist- zolpidem tartrate spray, metered

magna pharmaceuticals, inc. - zolpidem tartrate (unii: wy6w63843k) (zolpidem - unii:7k383oqi23) - zolpidem tartrate 5 mg - zolpimist (zolpidem tartrate) oral spray (zolpidem tartrate) is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. zolpidem tartrate has been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see clinical studies (14)] . the clinical trials performed in support of efficacy were 4-5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. zolpimist (zolpidem tartrate) oral spray is contraindicated in patients with known hypersensitivity to zolpidem. observed reactions with zolpidem include anaphylaxis and angioedema [see warnings and precautions (5.3)]. pregnancy category c there are no adequate and well-controlled studies of zolpimist (zolpidem tartrate) oral spray in pregnant women. studies in children to assess the effects of prenatal exposure to zolpidem have not been conducted; however, cases of severe neonatal respiratory depression have been reported when zolpidem was used

SUCROMATE™ EQUINE
(DESLORELIN ACETATE) USA - engelsk - NLM (National Library of Medicine)

sucromate™ equine (deslorelin acetate)

thorn bioscience - deslorelin acetate (unii: 679007nr5c) (deslorelin - unii:tkg3i66tve) - deslorelin acetate 1.8 mg in 1 ml - sucromate™ equine is contraindicated in horses known to be hyper - sensitive to deslorelin acetate. pregnant women and women of childbearing age should exercise caution when handling this product. accidental administration may lead to a disruption of the menstrual cycle. direct contact with the skin should be avoided. if exposure occurs, contact areas should be washed immediately with alcohol followed by soap and water, as this product is insoluble in water. in case of accidental human injection, consult a physician immediately. to obtain a copy of the material safety data sheet (msds) call thorn bioscience llc at 1-800-456-1403.

SCANDONEST L- mepivacaine hydrochloride and levonordefrin injection, solution USA - engelsk - NLM (National Library of Medicine)

scandonest l- mepivacaine hydrochloride and levonordefrin injection, solution

novocol pharmaceutical of canada, inc - mepivacaine hydrochloride (unii: 4vfx2l7em5) (mepivacaine - unii:b6e06qe59j), levonordefrin (unii: v008l6478d) (levonordefrin - unii:v008l6478d) - mepivacaine hydrochloride 20 mg in 1 ml - mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. scandonest® is contraindicated in patients with a known hypersensitivity to amide-type local anesthetics.

Fomepizole SERB 5 mg/mL, concentrate for solution for infusion. Irland - engelsk - HPRA (Health Products Regulatory Authority)

fomepizole serb 5 mg/ml, concentrate for solution for infusion.

serb s.a., - fomepizole sulphate - concentrate for solution for infusion - 5 milligram(s)/millilitre - antidotes; fomepizole